CORMEDIX INC. Operating Leases, Future Minimum Payments, Due in Rolling Year Three
CORMEDIX INC. (CRMD) had Operating Leases, Future Minimum Payments, Due in Rolling Year Three of $202.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree · last filed 2021-05-13
- 2021-03-31: Operating Leases, Future Minimum Payments, Due in Rolling Year Three $202.00K.
- 2020-12-31: Operating Leases, Future Minimum Payments, Due in Rolling Year Three $202.00K.
- 2020-09-30: Operating Leases, Future Minimum Payments, Due in Rolling Year Three $200.00K.
- 2020-06-30: Operating Leases, Future Minimum Payments, Due in Rolling Year Three $1.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Rolling Year Three |
|---|---|
| 2021-03-31 | $202.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $202.00K 10-K · filed 2021-03-30 |
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.00K 10-K · filed 2020-03-16 |
| 2019-09-30 | $2.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $2.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.00K 10-Q · filed 2019-05-13 |
| 2015-09-30 | $60.78K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $60.78K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $60.78K 10-Q · filed 2015-05-07 |
| 2012-12-31 | $20.89K 10-K/A · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |